CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 74 filers reported holding CITIUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $33,569 | -43.0% | 49,049 | 0.0% | 0.00% | – |
Q2 2023 | $58,859 | -0.2% | 49,049 | +50.0% | 0.00% | – |
Q1 2022 | $59,000 | +20.4% | 32,709 | +2.3% | 0.00% | – |
Q4 2021 | $49,000 | -55.5% | 31,989 | -41.4% | 0.00% | – |
Q3 2021 | $110,000 | -27.6% | 54,583 | +24.9% | 0.00% | – |
Q2 2021 | $152,000 | – | 43,695 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GSA CAPITAL PARTNERS LLP | 498,783 | $394 | 0.05% |
Inspire Advisors, LLC | 195,946 | $154,797 | 0.04% |
Wealth Advisory Solutions, LLC | 155,850 | $123,122 | 0.03% |
Miller Investment Management, LP | 50,000 | $39,500 | 0.01% |
Virtu Financial LLC | 39,005 | $31 | 0.00% |
Pasadena Private Wealth, LLC | 10,965 | $8,662 | 0.00% |
Jump Financial, LLC | 49,251 | $38,908 | 0.00% |
Csenge Advisory Group | 15,000 | $11,850 | 0.00% |
Qube Research & Technologies Ltd | 120,580 | $95,258 | 0.00% |
Syverson Strege & Co | 2,145 | $1,695 | 0.00% |